You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

920 Results
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2023
Drug
Other Name(s): Proleukin® (interleukin-2)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): MabCampath®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2019
Drug
Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2016
Drug
Other Name(s): Zytiga®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2024
Drug
Other Name(s): Inlyta®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Trisenox®
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2023
Drug
Other Name(s): Giotrif®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Tagrisso®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2024
Drug
Other Name(s): Alecensaro®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Drug
Other Name(s): Agrylin®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
aldesleukin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2019

Pages